நாட்பட்ட நுரையீரல் அடைப்பு நோய் (Tamil Wikipedia)

Analysis of information sources in references of the Wikipedia article "நாட்பட்ட நுரையீரல் அடைப்பு நோய்" in Tamil language version.

refsWebsite

Global rank Tamil rank

138nih.gov

4^th place

5^th place

98doi.org

2^nd place

4^th place

27google.ca

838^th place

110^th place

6who.int

195^th place

53^rd place

6web.archive.org

1^st place

5archive.org

6^th place

8^th place

4elsevier.com

610^th place

321^st place

4atsjournals.org

low place

2,309^th place

3goldcopd.org

low place

1,215^th place

2plos.org

2,112^th place

3,930^th place

2pubmedcentral.gov

low place

131^st place

2medicinenet.com

3,840^th place

831^st place

2nice.org.uk

3,258^th place

310^th place

2books.google.com

3^rd place

6^th place

2nhs.uk

1,989^th place

472^nd place

2cdc.gov

218^th place

72^nd place

2chestpubs.org

low place

3,217^th place

2wikipedia.org

low place

1ebmedicine.net

low place

3,398^th place

1cancer.gov

1,684^th place

140^th place

1toolserver.org

low place

352^nd place

1thoracic.org

low place

1brit-thoracic.org.uk

low place

1hse.gov.uk

8,579^th place

low place

1chestjournal.org

low place

4,111^th place

1chestnet.org

low place

1ersjournals.com

low place

5,532^nd place

1wrongdiagnosis.com

low place

3,879^th place

1ahrq.gov

9,469^th place

798^th place

1reference.com

657^th place

89^th place

1thefreedictionary.com

614^th place

126^th place

1gov.uk

432^nd place

2,452^nd place

1weforum.org

1,771^st place

1,808^th place

ahrq.gov

hcup-us.ahrq.gov

Torio CM, Andrews RM (2006). "National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160". Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (Agency for Health Care Policy and Research). பப்மெட்:24199255. http://hcup-us.ahrq.gov/reports/statbriefs/sb160.jsp. பார்த்த நாள்: 2014-10-19.

archive.org

Pirozzi C, Scholand MB (July 2012). "Smoking cessation and environmental hygiene". Med. Clin. North Am. 96 (4): 849–67. doi:10.1016/j.mcna.2012.04.014. பப்மெட்:22793948. https://archive.org/details/sim_medical-clinics-of-north-america_2012-07_96_4/page/849.
Torres M, Moayedi S (May 2007). "Evaluation of the acutely dyspneic elderly patient". Clin. Geriatr. Med. 23 (2): 307–25, vi. doi:10.1016/j.cger.2007.01.007. பப்மெட்:17462519. https://archive.org/details/sim_clinics-in-geriatric-medicine_2007-05_23_2/page/307.
Badgett RG, Tanaka DJ, Hunt DK, et al. (1994). "The clinical evaluation for diagnosing obstructive airways disease in high-risk patients". Chest 106 (5): 1427–31. doi:10.1378/chest.106.1427. பப்மெட்:7956395. https://archive.org/details/sim_chest_1994-11_106_5/page/1427.
Celli BR, Cote CG, Marin JM, et al. (March 2004). "The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease". N. Engl. J. Med. 350 (10): 1005–12. doi:10.1056/NEJMoa021322. பப்மெட்:14999112. https://archive.org/details/sim_new-england-journal-of-medicine_2004-03-04_350_10/page/n87.
Mackay AJ, Hurst JR (July 2012). "COPD exacerbations: causes, prevention, and treatment". Med. Clin. North Am. 96 (4): 789–809. doi:10.1016/j.mcna.2012.02.008. பப்மெட்:22793945. https://archive.org/details/sim_medical-clinics-of-north-america_2012-07_96_4/page/789.

atsjournals.org

ajrccm.atsjournals.org

Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J (September 2007). "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary". Am. J. Respir. Crit. Care Med. 176 (6): 532–55. doi:10.1164/rccm.200703-456SO. பப்மெட்:17507545. http://ajrccm.atsjournals.org/content/176/6/532.long.
Silverman EK, Chapman HA, Drazen JM, et al. (June 1998). "Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis". Am. J. Respir. Crit. Care Med. 157 (6 Pt 1): 1770–8. பப்மெட்:9620904. http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=9620904.

pats.atsjournals.org

Kennedy SM, Chambers R, Du W, Dimich-Ward H (December 2007). "Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?". Proceedings of the American Thoracic Society 4 (8): 692–4. doi:10.1513/pats.200707-094SD. பப்மெட்:18073405. http://pats.atsjournals.org/cgi/content/full/4/8/692.
Kennedy SM, Chambers R, Du W, Dimich-Ward H (December 2007). "Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?". Proceedings of the American Thoracic Society 4 (8): 692–4. doi:10.1513/pats.200707-094SD. பப்மெட்:18073405. http://pats.atsjournals.org/cgi/content/full/4/8/692.

books.google.com

Anita Sharma ; with a contribution by David Pitchforth ; forewords by Gail Richards; Barclay, Joyce (2010). COPD in primary care. Oxford: Radcliffe Pub. p. 9. ISBN 978-1-84619-316-3.{{cite book}}: CS1 maint: multiple names: authors list (link)
George L. Waldbott (1965). A struggle with Titans. Carlton Press. p. 6.

brit-thoracic.org.uk

BTS COPD Consortium (2005). "Spirometry in practice - a practical guide to using spirometry in primary care". pp. 8–9. Archived from the original on 26 ஆகஸ்ட் 2014. Retrieved 25 August 2014. {{cite web}}: Check date values in: |archive-date= (help)

cancer.gov

"Definition of pack year - NCI Dictionary of Cancer Terms". Archived from the original on 2009-05-10.

cdc.gov

Handbook for Dust Control in Mining. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2003-147, Information Circular 9465, 2003 Jun; :1-131. அணுக்கம்செய்யப்பட்டது மார்ச் 26, 2009.
Centers for Disease Control and Prevention (Nov 23, 2012). "Chronic Obstructive Pulmonary Disease Among Adults — United States, 2011". Morbidity and Mortality Weekly Report 61 (46): 938–43. பப்மெட்:23169314. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a2.htm.

chestjournal.org

Liesker JJ, Wijkstra PJ, Ten Hacken NH, Koëter GH, Postma DS, Kerstjens HA (February 2002). "A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD". Chest 121 (2): 597–608. doi:10.1378/chest.121.2.597. பப்மெட்:11834677. http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=11834677. ^{[தொடர்பிழந்த இணைப்பு]}

chestnet.org

journal.publications.chestnet.org

Liesker JJ, Wijkstra PJ, Ten Hacken NH, Koëter GH, Postma DS, Kerstjens HA (February 2002). "A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD". Chest 121 (2): 597–608. doi:10.1378/chest.121.2.597. பப்மெட்:11834677. http://journal.publications.chestnet.org/article.aspx?articleid=1080303.

chestpubs.org

chestjournal.chestpubs.org

Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD (January 2010). "Cardiovascular events associated with ipratropium bromide in COPD". Chest 137 (1): 13–9. doi:10.1378/chest.08-2367. பப்மெட்:19363211. http://chestjournal.chestpubs.org/content/137/1/13.abstract.
Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP (January 2010). "Cardiovascular safety of tiotropium in patients with COPD". Chest 137 (1): 20–30. doi:10.1378/chest.09-0011. பப்மெட்:19592475. http://chestjournal.chestpubs.org/content/137/1/20.abstract.

doi.org

dx.doi.org

Rabe KF, Hurd S, Anzueto A, et al. (2007). "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary". Am. J. Respir. Crit. Care Med. 176 (6): 532–55. doi:10.1164/rccm.200703-456SO. பப்மெட்:17507545.
Hogg JC, Chu F, Utokaparch S, et al. (2004). "The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease". N. Engl. J. Med. 350 (26): 2645–53. doi:10.1056/NEJMoa032158. பப்மெட்:15215480.
Decramer M, Janssens W, Miravitlles M (April 2012). "நாட்பட்ட நுரையீரல் அடைப்பு வளர்ந்து வரும் நோய்". Lancet 379 (9823): 1341–51. doi:10.1016/S0140-6736(11)60968-9. பப்மெட்:22314182.
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J (September 2007). "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary". Am. J. Respir. Crit. Care Med. 176 (6): 532–55. doi:10.1164/rccm.200703-456SO. பப்மெட்:17507545. http://ajrccm.atsjournals.org/content/176/6/532.long.
Nathell L, Nathell M, Malmberg P, Larsson K (2007). "COPD diagnosis related to different guidelines and spirometry techniques". Respir. Res. 8 (1): 89. doi:10.1186/1465-9921-8-89. பப்மெட்:18053200.
Mathers CD, Loncar D (November 2006). "Projections of global mortality and burden of disease from 2002 to 2030". PLoS Med. 3 (11): e442. doi:10.1371/journal.pmed.0030442. பப்மெட்:17132052. பப்மெட் சென்ட்ரல்:1664601. http://dx.plos.org/10.1371/journal.pmed.0030442.
Mathers CD, Loncar D (November 2006). "Projections of Global Mortality and Burden of Disease from 2002 to 2030". PLoS Med. 3 (11): e442. doi:10.1371/journal.pmed.0030442. பப்மெட்:17132052. பப்மெட் சென்ட்ரல்:1664601. http://dx.plos.org/10.1371/journal.pmed.0030442.
Mahler DA (2006). "Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease". Proceedings of the American Thoracic Society 3 (3): 234–8. doi:10.1513/pats.200509-103SF. பப்மெட்:16636091.
Holland AE, Hill CJ, Jones AY, McDonald CF (2012). Holland, Anne E. ed. "Breathing exercises for chronic obstructive pulmonary disease". Cochrane Database Syst Rev 10: CD008250. doi:10.1002/14651858.CD008250.pub2. பப்மெட்:23076942.
Weitzenblum E, Chaouat A (2009). "Cor pulmonale". Chron Respir Dis 6 (3): 177–85. doi:10.1177/1479972309104664. பப்மெட்:19643833.
Brulotte CA, Lang ES (May 2012). "Acute exacerbations of chronic obstructive pulmonary disease in the emergency department". Emerg. Med. Clin. North Am. 30 (2): 223–47, vii. doi:10.1016/j.emc.2011.10.005. பப்மெட்:22487106.
Laniado-Laborín, R (January 2009). "Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21st century". International journal of environmental research and public health 6 (1): 209–24. doi:10.3390/ijerph6010209. பப்மெட்:19440278.
Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD (August 2009). "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history". Eur. Respir. J. 34 (2): 380–6. doi:10.1183/09031936.00144208. பப்மெட்:19196816.
எஆசு:10.1016/S0140-6736(06)68516-4
This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand
Devereux, Graham (May 2006). "ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors". BMJ 332 (7550): 1142–4. doi:10.1136/bmj.332.7550.1142. பப்மெட்:16690673.
Hnizdo E, Vallyathan V (April 2003). "Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence". Occup Environ Med 60 (4): 237–43. doi:10.1136/oem.60.4.237. பப்மெட்:12660371.
Pirozzi C, Scholand MB (July 2012). "Smoking cessation and environmental hygiene". Med. Clin. North Am. 96 (4): 849–67. doi:10.1016/j.mcna.2012.04.014. பப்மெட்:22793948. https://archive.org/details/sim_medical-clinics-of-north-america_2012-07_96_4/page/849.
Devereux, Graham (2006). "Definition, epidemiology and risk factors". BMJ 332 (7550): 1142–4. doi:10.1136/bmj.332.7550.1142. பப்மெட்:16690673.
Rushton, Lesley (2007). "Chronic Obstructive Pulmonary Disease and Occupational Exposure to Silica". Reviews on Environmental Health 22 (4): 255–72. doi:10.1515/REVEH.2007.22.4.255. பப்மெட்:18351226.
Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM (September 2006). "Global burden of COPD: systematic review and meta-analysis". Eur. Respir. J. 28 (3): 523–32. doi:10.1183/09031936.06.00124605. பப்மெட்:16611654.
Kennedy SM, Chambers R, Du W, Dimich-Ward H (December 2007). "Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?". Proceedings of the American Thoracic Society 4 (8): 692–4. doi:10.1513/pats.200707-094SD. பப்மெட்:18073405. http://pats.atsjournals.org/cgi/content/full/4/8/692.
Kennedy SM, Chambers R, Du W, Dimich-Ward H (December 2007). "Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?". Proceedings of the American Thoracic Society 4 (8): 692–4. doi:10.1513/pats.200707-094SD. பப்மெட்:18073405. http://pats.atsjournals.org/cgi/content/full/4/8/692.
Foreman MG, Campos M, Celedón JC (July 2012). "Genes and chronic obstructive pulmonary disease". Med. Clin. North Am. 96 (4): 699–711. doi:10.1016/j.mcna.2012.02.006. பப்மெட்:22793939.
Brode SK, Ling SC, Chapman KR (September 2012). "Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease". CMAJ 184 (12): 1365–71. doi:10.1503/cmaj.111749. பப்மெட்:22761482.
Beasley, V; Joshi, PV; Singanayagam, A; Molyneaux, PL; Johnston, SL; Mallia, P (2012). "Lung microbiology and exacerbations in COPD". International journal of chronic obstructive pulmonary disease 7: 555–69. doi:10.2147/COPD.S28286. பப்மெட்:22969296.
Calverley PM, Koulouris NG (2005). "Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology". Eur Respir J 25 (1): 186–199. doi:10.1183/09031936.04.00113204. பப்மெட்:15640341.
O'Donnell DE (2006). "Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease". The Proceedings of the American Thoracic Society 3 (2): 180–4. doi:10.1513/pats.200508-093DO. பப்மெட்:16565429.
Agustí A, MacNee W, Donaldson K, Cosio M. (2003). "Hypothesis: does COPD have an autoimmune component?". Thorax 58 (10): 832–4. doi:10.1136/thorax.58.10.832. பப்மெட்:14514931.
Rutgers, Steven R.; Postma, Dirkje S.; Ten Hacken, Nick H. .T.; Kauffman, Henk F.;van der Mark,Thomas W; Koeter, Gerard H.; Timens, Wim (2000). "Ongoing airway inflammation in patients with COPD who do not currently smoke". Thorax 55 (1): 12–18. doi:10.1136/thorax.55.1.12. பப்மெட்:10607796.
Feghali-Bostwick CA, Gadgil AS, Otterbein LE, et al. (January 2008). "Autoantibodies in patients with chronic obstructive pulmonary disease". Am. J. Respir. Crit. Care Med. 177 (2): 156–63. doi:10.1164/rccm.200701-014OC. பப்மெட்:17975205.
Lee SH, Goswami S, Grudo A, et al. (May 2007). "Antielastin autoimmunity in tobacco smoking-induced emphysema". Nat. Med. 13 (5): 567–9. doi:10.1038/nm1583. பப்மெட்:17450149.
Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P (August 2011). "Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society". Ann. Intern. Med. 155 (3): 179–91. doi:10.7326/0003-4819-155-3-201108020-00008. பப்மெட்:21810710.
Kitaguchi Y, Fujimoto K, Kubo K, Honda T (October 2006). "Characteristics of COPD phenotypes classified according to the findings of HRCT". Respir Med 100 (10): 1742–52. doi:10.1016/j.rmed.2006.02.003. பப்மெட்:16549342. http://linkinghub.elsevier.com/retrieve/pii/S0954-6111(06)00064-3.
Paoletti M, Camiciottoli G, Meoni E, et al. (December 2009). "Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes". J Biomed Inform 42 (6): 1013–21. doi:10.1016/j.jbi.2009.05.008. பப்மெட்:19501190. http://linkinghub.elsevier.com/retrieve/pii/S1532-0464(09)00080-X.
Petty TL (2002). "COPD: clinical phenotypes". Pulm Pharmacol Ther 15 (4): 341–51. doi:10.1006/pupt.2002.0380. பப்மெட்:12220938. http://linkinghub.elsevier.com/retrieve/pii/S1094-5539(02)90380-9.
Torres M, Moayedi S (May 2007). "Evaluation of the acutely dyspneic elderly patient". Clin. Geriatr. Med. 23 (2): 307–25, vi. doi:10.1016/j.cger.2007.01.007. பப்மெட்:17462519. https://archive.org/details/sim_clinics-in-geriatric-medicine_2007-05_23_2/page/307.
Badgett RG, Tanaka DJ, Hunt DK, et al. (1994). "The clinical evaluation for diagnosing obstructive airways disease in high-risk patients". Chest 106 (5): 1427–31. doi:10.1378/chest.106.1427. பப்மெட்:7956395. https://archive.org/details/sim_chest_1994-11_106_5/page/1427.
Holleman DR, Simel DL (1995). "Does the clinical examination predict airflow limitation?". JAMA 273 (4): 313–9. doi:10.1001/jama.273.4.313. பப்மெட்:7815660.
Celli BR, Cote CG, Marin JM, et al. (March 2004). "The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease". N. Engl. J. Med. 350 (10): 1005–12. doi:10.1056/NEJMoa021322. பப்மெட்:14999112. https://archive.org/details/sim_new-england-journal-of-medicine_2004-03-04_350_10/page/n87.
Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E (November 2008). "Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis". JAMA 300 (20): 2407–16. doi:10.1001/jama.2008.717. பப்மெட்:19033591.
Mackay AJ, Hurst JR (July 2012). "COPD exacerbations: causes, prevention, and treatment". Med. Clin. North Am. 96 (4): 789–809. doi:10.1016/j.mcna.2012.02.008. பப்மெட்:22793945. https://archive.org/details/sim_medical-clinics-of-north-america_2012-07_96_4/page/789.
Poole PJ, Chacko E, Wood-Baker RW, Cates CJ (2006). Poole, Phillippa. ed. "Influenza vaccine for patients with chronic obstructive pulmonary disease". Cochrane Database Syst Rev (1): CD002733. doi:10.1002/14651858.CD002733.pub2. பப்மெட்:16437444.
Tønnesen P (March 2013). "Smoking cessation and COPD". Eur Respir Rev 22 (127): 37–43. doi:10.1183/09059180.00007212. பப்மெட்:23457163.
Carlucci A, Guerrieri A, Nava S (December 2012). "Palliative care in COPD patients: is it only an end-of-life issue?". Eur Respir Rev 21 (126): 347–54. doi:10.1183/09059180.00001512. பப்மெட்:23204123.
Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J (2011). Puhan, Milo A. ed. "Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease". Cochrane Database Syst Rev (10): CD005305. doi:10.1002/14651858.CD005305.pub3. பப்மெட்:21975749.
Lacasse Y, Goldstein R, Lasserson TJ, Martin S (2006). Lacasse, Yves. ed. "Pulmonary rehabilitation for chronic obstructive pulmonary disease". Cochrane Database Syst Rev (4): CD003793. doi:10.1002/14651858.CD003793.pub2. பப்மெட்:17054186.
Ferreira IM, Brooks D, White J, Goldstein R (2012). Ferreira, Ivone M. ed. "Nutritional supplementation for stable chronic obstructive pulmonary disease". Cochrane Database Syst Rev 12: CD000998. doi:10.1002/14651858.CD000998.pub3. பப்மெட்:23235577.
Liesker JJ, Wijkstra PJ, Ten Hacken NH, Koëter GH, Postma DS, Kerstjens HA (February 2002). "A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD". Chest 121 (2): 597–608. doi:10.1378/chest.121.2.597. பப்மெட்:11834677. http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=11834677. ^{[தொடர்பிழந்த இணைப்பு]}
van Dijk WD, van den Bemt L, van Weel C (2013). "Megatrials for bronchodilators in chronic obstructive pulmonary disease (COPD) treatment: time to reflect". J Am Board Fam Med 26 (2): 221–4. doi:10.3122/jabfm.2013.02.110342. பப்மெட்:23471939.
Liesker JJ, Wijkstra PJ, Ten Hacken NH, Koëter GH, Postma DS, Kerstjens HA (February 2002). "A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD". Chest 121 (2): 597–608. doi:10.1378/chest.121.2.597. பப்மெட்:11834677. http://journal.publications.chestnet.org/article.aspx?articleid=1080303.
Salpeter SR, Buckley NS, Salpeter EE (October 2006). "Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD". J Gen Intern Med 21 (10): 1011–9. doi:10.1111/j.1525-1497.2006.00507.x. பப்மெட்:16970553.
Chong J, Karner C, Poole P (2012). Chong, Jimmy. ed. "Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease". Cochrane Database Syst Rev 9: CD009157. doi:10.1002/14651858.CD009157.pub2. பப்மெட்:22972134.
Karner C, Cates CJ (2012). Karner, Charlotta. ed. "Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease". Cochrane Database Syst Rev 4: CD008989. doi:10.1002/14651858.CD008989.pub2. பப்மெட்:22513969.
Calverley PM, Anderson JA, Celli B, et al. (2007). "Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease". N. Engl. J. Med. 356 (8): 775–89. doi:10.1056/NEJMoa063070. பப்மெட்:17314337.
Cave, AC.; Hurst, MM. (May 2011). "The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis". Pharmacol Ther 130 (2): 114–43. doi:10.1016/j.pharmthera.2010.12.008. பப்மெட்:21276815.
Spencer, S; Karner, C; Cates, CJ; Evans, DJ (Dec 7, 2011). Spencer, Sally. ed. "Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease". The Cochrane database of systematic reviews (12): CD007033. doi:10.1002/14651858.CD007033.pub3. பப்மெட்:22161409.
Wang, J; Nie, B; Xiong, W; Xu, Y (April 2012). "Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis". Journal of clinical pharmacy and therapeutics 37 (2): 204–11. doi:10.1111/j.1365-2710.2011.01285.x. பப்மெட்:21740451.
Decramer ML, Hanania NA, Lötvall JO, Yawn BP (2013). "The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease". Int J Chron Obstruct Pulmon Dis 8: 53–64. doi:10.2147/COPD.S39018. பப்மெட்:23378756.
Nannini, LJ; Lasserson, TJ; Poole, P (Sep 12, 2012). Nannini, Luis Javier. ed. "Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease". The Cochrane database of systematic reviews 9: CD006829. doi:10.1002/14651858.CD006829.pub2. பப்மெட்:22972099.
Tashkin DP, Celli B, Senn S, et al. (October 2008). "A 4-year trial of tiotropium in chronic obstructive pulmonary disease". N. Engl. J. Med. 359 (15): 1543–54. doi:10.1056/NEJMoa0805800. பப்மெட்:18836213.
O'Donnell DE, Flüge T, Gerken F, et al. (June 2004). "Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD". Eur Respir J 23 (6): 832–40. doi:10.1183/09031936.04.00116004. பப்மெட்:15218994. http://erj.ersjournals.com/cgi/pmidlookup?view=long&pmid=15218994.
Cheyne L, Irvin-Sellers MJ, White J (Sep 16, 2013). Cheyne, Leanne. ed. "Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease". Cochrane Database of Systematic Reviews 9 (9): CD009552. doi:10.1002/14651858.CD009552.pub2. பப்மெட்:24043433.
Karner, C; Chong, J; Poole, P (Jul 11, 2012). Karner, Charlotta. ed. "Tiotropium versus placebo for chronic obstructive pulmonary disease". The Cochrane database of systematic reviews 7: CD009285. doi:10.1002/14651858.CD009285.pub2. பப்மெட்:22786525.
Singh S, Loke YK, Furberg CD (September 2008). "Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis". JAMA 300 (12): 1439–50. doi:10.1001/jama.300.12.1439. பப்மெட்:18812535.
Singh S, Loke YK, Enright P, Furberg CD (January 2013). "Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications". Thorax 68 (1): 114–6. doi:10.1136/thoraxjnl-2011-201275. பப்மெட்:22764216.
Jones, P (Apr 2013). "Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review.". Advances in therapy 30 (4): 354–68. doi:10.1007/s12325-013-0019-2. பப்மெட்:23553509.
Cazzola, M; Page, CP; Matera, MG (Jun 2013). "Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.". Expert opinion on pharmacotherapy 14 (9): 1205–14. doi:10.1517/14656566.2013.789021. பப்மெட்:23566013.
Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD (January 2010). "Cardiovascular events associated with ipratropium bromide in COPD". Chest 137 (1): 13–9. doi:10.1378/chest.08-2367. பப்மெட்:19363211. http://chestjournal.chestpubs.org/content/137/1/13.abstract.
Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP (January 2010). "Cardiovascular safety of tiotropium in patients with COPD". Chest 137 (1): 20–30. doi:10.1378/chest.09-0011. பப்மெட்:19592475. http://chestjournal.chestpubs.org/content/137/1/20.abstract.
Pinto-Plata VM, Müllerova H, Toso JF, et al. (January 2006). "C-reactive protein in patients with COPD, control smokers and non-smokers". Thorax 61 (1): 23–8. doi:10.1136/thx.2005.042200. பப்மெட்:16143583.
Gartlehner G, Hansen RA, Carson SS, Lohr KN (2006). "Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes". Ann Fam Med 4 (3): 253–62. doi:10.1370/afm.517. பப்மெட்:16735528.
Gartlehner G, Hansen RA, Carson SS, Lohr KN (2006). "Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes". Ann Fam Med 4 (3): 253–62. doi:10.1370/afm.517. பப்மெட்:16735528.
Shafazand S (June 2013). "ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPD". Ann. Intern. Med. 158 (12): JC2. doi:10.7326/0003-4819-158-12-201306180-02002. பப்மெட்:23778926.
Zhou Y, Wang X, Zeng X, et al. (2006). "Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year". Respirology 11 (5): 603–10. doi:10.1111/j.1440-1843.2006.00897.x. பப்மெட்:16916334.
Rennard SI, Fogarty C, Kelsen S, et al. (May 2007). "The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease". Am. J. Respir. Crit. Care Med. 175 (9): 926–34. doi:10.1164/rccm.200607-995OC. பப்மெட்:17290043.
Herath, SC; Poole, P (Nov 28, 2013). "Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).". The Cochrane database of systematic reviews 11: CD009764. doi:10.1002/14651858.CD009764.pub2. பப்மெட்:24288145.
Simoens, S; Laekeman, G; Decramer, M (May 2013). "Preventing COPD exacerbations with macrolides: a review and budget impact analysis". Respiratory medicine 107 (5): 637–48. doi:10.1016/j.rmed.2012.12.019. பப்மெட்:23352223.
Barr RG, Rowe BH, Camargo CA (2003). Barr, R Graham. ed. "Methylxanthines for exacerbations of chronic obstructive pulmonary disease". Cochrane Database Syst Rev (2): CD002168. doi:10.1002/14651858.CD002168. பப்மெட்:12804425.
Bradley JM, O'Neill B (2005). Bradley, Judy M. ed. "Short-term ambulatory oxygen for chronic obstructive pulmonary disease". Cochrane Database Syst Rev (4): CD004356. doi:10.1002/14651858.CD004356.pub3. பப்மெட்:16235359.
Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A (2011). Abernethy, Amy. ed. "Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease". Cochrane Database Syst Rev (6): CD006429. doi:10.1002/14651858.CD006429.pub2. பப்மெட்:21678356.
O'Driscoll, BR; Howard, LS; Davison, AG; British Thoracic, Society (October 2008). "BTS guideline for emergency oxygen use in adult patients". Thorax 63 (Suppl 6): vi1–68. doi:10.1136/thx.2008.102947. பப்மெட்:18838559.
Lacasse Y, Brosseau L, Milne S, et al. (2002). "Pulmonary rehabilitation for chronic obstructive pulmonary disease". Cochrane database of systematic reviews (Online) (3): CD003793. doi:10.1002/14651858.CD003793. பப்மெட்:12137716.
Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA (2012). Vollenweider, Daniela J. ed. "Antibiotics for exacerbations of chronic obstructive pulmonary disease". Cochrane Database Syst Rev 12: CD010257. doi:10.1002/14651858.CD010257. பப்மெட்:23235687.
Jeppesen, E; Brurberg, KG; Vist, GE; Wedzicha, JA; Wright, JJ; Greenstone, M; Walters, JA (May 16, 2012). "Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.". The Cochrane database of systematic reviews 5: CD003573. doi:10.1002/14651858.CD003573.pub2. பப்மெட்:22592692.
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, et al. (December 2012). "Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet 380 (9859): 2197–223. doi:10.1016/S0140-6736(12)61689-4. பப்மெட்:23245608.
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al. (December 2012). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. பப்மெட்:23245607.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, et al. (December 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. பப்மெட்:23245604.
Rycroft CE, Heyes A, Lanza L, Becker K (2012). "Epidemiology of chronic obstructive pulmonary disease: a literature review". Int J Chron Obstruct Pulmon Dis 7: 457–94. doi:10.2147/COPD.S32330. பப்மெட்:22927753.
Simpson CR, Hippisley-Cox J, Sheikh A (2010). "Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients". Brit J Gen Pract 60 (576): 483–. doi:10.3399/bjgp10X514729. பப்மெட்:20594429.
Ziment, Irwin (1991). "History of the Treatment of Chronic Bronchitis". Respiration 58 (Suppl 1): 37–42. doi:10.1159/000195969. பப்மெட்:1925077.
Petty TL (2006). "The history of COPD". Int J Chron Obstruct Pulmon Dis 1 (1): 3–14. doi:10.2147/copd.2006.1.1.3. பப்மெட்:18046898.
Fishman AP (May 2005). "One hundred years of chronic obstructive pulmonary disease". Am. J. Respir. Crit. Care Med. 171 (9): 941–8. doi:10.1164/rccm.200412-1685OE. பப்மெட்:15849329.
Fishman AP (May 2005). "One hundred years of chronic obstructive pulmonary disease". Am. J. Respir. Crit. Care Med. 171 (9): 941–8. doi:10.1164/rccm.200412-1685OE. பப்மெட்:15849329.
Inamdar, AC; Inamdar, AA (Oct 2013). "Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.". Experimental lung research 39 (8): 315–27. doi:10.3109/01902148.2013.816803. பப்மெட்:23992090.
Conese, M; Piro, D; Carbone, A; Castellani, S; Di Gioia, S (2014). "Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity.". TheScientificWorldJournal 2014: 859817. doi:10.1155/2014/859817. பப்மெட்:24563632.
Wright, JL; Churg, A (December 2002). "Animal models of cigarette smoke-induced COPD". Chest 122 (6 Suppl): 301S–6S. doi:10.1378/chest.122.6_suppl.301S. பப்மெட்:12475805.
Churg, A; Wright, JL (2007). "Animal models of cigarette smoke-induced chronic obstructive lung disease". Contributions to microbiology. Contributions to Microbiology 14: 113–25. doi:10.1159/000107058. பன்னாட்டுத் தரப்புத்தக எண்:3-8055-8332-X. பப்மெட்:17684336.
Marinkovic D, Aleksic-Kovacevic S, Plamenac P (2007). "Cellular basis of chronic obstructive pulmonary disease in horses". Int. Rev. Cytol.. International Review of Cytology 257: 213–47. doi:10.1016/S0074-7696(07)57006-3. பன்னாட்டுத் தரப்புத்தக எண்:978-0-12-373701-4. பப்மெட்:17280899.

ebmedicine.net

Gruber, Phillip (November 2008). "The Acute Presentation of Chronic Obstructive Pulmonary Disease In the Emergency Department: A Challenging Oxymoron". Emergency Medicine Practice 10 (11). http://www.ebmedicine.net/topics.php?paction=showTopic&topic_id=63.

elsevier.com

linkinghub.elsevier.com

Kitaguchi Y, Fujimoto K, Kubo K, Honda T (October 2006). "Characteristics of COPD phenotypes classified according to the findings of HRCT". Respir Med 100 (10): 1742–52. doi:10.1016/j.rmed.2006.02.003. பப்மெட்:16549342. http://linkinghub.elsevier.com/retrieve/pii/S0954-6111(06)00064-3.
Paoletti M, Camiciottoli G, Meoni E, et al. (December 2009). "Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes". J Biomed Inform 42 (6): 1013–21. doi:10.1016/j.jbi.2009.05.008. பப்மெட்:19501190. http://linkinghub.elsevier.com/retrieve/pii/S1532-0464(09)00080-X.
Petty TL (2002). "COPD: clinical phenotypes". Pulm Pharmacol Ther 15 (4): 341–51. doi:10.1006/pupt.2002.0380. பப்மெட்:12220938. http://linkinghub.elsevier.com/retrieve/pii/S1094-5539(02)90380-9.
"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party". Lancet 1 (8222): 681–6. March 1981. பப்மெட்:6110912. http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(81)91970-X.

ersjournals.com

erj.ersjournals.com

O'Donnell DE, Flüge T, Gerken F, et al. (June 2004). "Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD". Eur Respir J 23 (6): 832–40. doi:10.1183/09031936.04.00116004. பப்மெட்:15218994. http://erj.ersjournals.com/cgi/pmidlookup?view=long&pmid=15218994.

goldcopd.org

Global Initiative for Chronic Obstructive Lung Disease.
Vestbo, Jørgen (2013). "Introduction". Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (PDF). Global Initiative for Chronic Obstructive Lung Disease. pp. xiii–xv. Archived from the original (PDF) on 2013-10-04. Retrieved 2014-10-19. {{cite book}}: Unknown parameter |nopp= ignored (help)
Vestbo, Jørgen (2013). "Management of Stable COPD". Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (PDF). Global Initiative for Chronic Obstructive Lung Disease. pp. 31–8. Archived from the original (PDF) on 2013-10-04. Retrieved 2014-10-19.

google.ca

books.google.ca

Lomborg, Bjørn (2013). Global problems, local solutions : costs and benefits. Cambridge University Pres. p. 143. ISBN 978-1-107-03959-9.
Morrison, [edited by] Nathan E. Goldstein, R. Sean (2013). Evidence-based practice of palliative medicine. Philadelphia: Elsevier/Saunders. p. 124. ISBN 978-1-4377-3796-7. {{cite book}}: |first= has generic name (help)CS1 maint: multiple names: authors list (link)
Mandell, editors, James K. Stoller, Franklin A. Michota, Jr., Brian F. (2009). The Cleveland Clinic Foundation intensive review of internal medicine (5th ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 419. ISBN 978-0-7817-9079-6. {{cite book}}: |first= has generic name (help)CS1 maint: multiple names: authors list (link)
Spiro, Stephen (2012). Clinical respiratory medicine expert consult (4th ed.). Philadelphia, PA: Saunders. p. Chapter 43. ISBN 978-1-4557-2329-4.
Ward, Helen (2012). Oxford Handbook of Epidemiology for Clinicians. Oxford University Press. pp. 289–290. ISBN 978-0-19-165478-7.
Rennard, Stephen (2013). Clinical management of chronic obstructive pulmonary disease (2nd ed.). New York: Informa Healthcare. p. 23. ISBN 978-0-8493-7588-0.
Goldman, Lee (2012). Goldman's Cecil medicine (24th ed.). Philadelphia: Elsevier/Saunders. p. 537. ISBN 978-1-4377-1604-7.
Laine, Christine (2009). In the Clinic: Practical Information about Common Health Problems. ACP Press. p. 226. ISBN 978-1-934465-64-6.
Dhar, Raja (2011). Textbook of pulmonary and critical care medicine. New Delhi: Jaypee Brothers Medical Publishers. p. 1056. ISBN 978-93-5025-073-0.
Palange, Paolo (2013). ERS Handbook of Respiratory Medicine. European Respiratory Society. p. 194. ISBN 978-1-84984-041-5.
Lötvall, Jan (2011). Advances in combination therapy for asthma and COPD. Chichester, West Sussex: John Wiley & Sons. p. 251. ISBN 978-1-119-97846-6.
Barnes, Peter (2009). Asthma and COPD : basic mechanisms and clinical management (2nd ed.). Amsterdam: Academic. p. 837. ISBN 978-0-12-374001-4.
Hanania, Nicola (2010-12-09). COPD a Guide to Diagnosis and Clinical Management (1st ed.). Totowa, NJ: Springer Science+Business Media, LLC. p. 197. ISBN 978-1-59745-357-8.
Currie, Graeme P. (2010). ABC of COPD (2nd ed.). Chichester, West Sussex, UK: Wiley-Blackwell, BMJ Books. p. 32. ISBN 978-1-4443-2948-3.
Young, Vincent B. (2010). Blueprints medicine (5th ed.). Philadelphia: Wolters Kluwer Health/Lippincott William & Wilkins. p. 69. ISBN 978-0-7817-8870-0.
Smith, Barbara K. Timby, Nancy E. (2005). Essentials of nursing : care of adults and children. Philadelphia: Lippincott Williams & Wilkins. p. 338. ISBN 978-0-7817-5098-1.{{cite book}}: CS1 maint: multiple names: authors list (link)
Rom, William N.; Markowitz, Steven B., eds. (2007). Environmental and occupational medicine (4th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. pp. 521–2. ISBN 978-0-7817-6299-1.
George, Ronald B. (2005). Chest medicine : essentials of pulmonary and critical care medicine (5th ed.). Philadelphia, PA: Lippincott Williams & Wilkins. p. 172. ISBN 978-0-7817-5273-2.
Chapman, Stephen (2009). Oxford handbook of respiratory medicine (2nd ed.). Oxford: Oxford University Press. p. 707. ISBN 978-0-19-954516-2.
Blackler, Laura (2007). Managing chronic obstructive pulmonary disease. Chichester, England: John Wiley & Sons. p. 49. ISBN 978-0-470-51798-7.
Jindal, Surinder K (2013). Chronic Obstructive Pulmonary Disease. Jaypee Brothers Medical. p. 139. ISBN 978-93-5090-353-7.
Medicine, prepared by the Department of Medicine, Washington University School of (2009). The Washington manual general internal medicine subspecialty consult (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 96. ISBN 978-0-7817-9155-7.{{cite book}}: CS1 maint: multiple names: authors list (link)
Yuh-Chin, T. Huang (2012-10-28). A clinical guide to occupational and environmental lung diseases. [New York]: Humana Press. p. 266. ISBN 978-1-62703-149-3.
Weinberger, Steven E. (2013-05-08). Principles of pulmonary medicine (6th ed.). Philadelphia: Elsevier/Saunders. p. 165. ISBN 978-1-62703-149-3.
Des Jardins, Terry (2013). Clinical Manifestations & Assessment of Respiratory Disease (6th ed.). Elsevier Health Sciences. p. 176. ISBN 978-0-323-27749-5.
Nici, Linda (2011). Chronic Obstructive Pulmonary Disease: Co-Morbidities and Systemic Consequences. Springer. p. 78. ISBN 978-1-60761-673-3.
Akers, R. Michael; Denbow, D. Michael (2008). Anatomy and Physiology of Domestic Animals. Arnes, AI: Wiley. p. 852. ISBN 978-1-118-70115-7.

gov.uk

An outcomes strategy for people with chronic obstructive pulmonary disease (COPD) and asthma in England (PDF). Department of Health. 18 July 2011. p. 5. Retrieved 27 November 2013.

hse.gov.uk

"Wet cutting". Health and Safety Executive. Retrieved November 29, 2013.

medicinenet.com

"MedicineNet.com - COPD signs & symptoms". Archived from the original on 2010-06-04. Retrieved 2010-06-03.
"MedicineNet.com - COPD causes". Archived from the original on 2010-06-03. Retrieved 2010-06-03.

nhs.uk

"Why is smoking addictive?". NHS Choices. December 29, 2011. Retrieved November 29, 2013.
"Why is smoking addictive?". NHS Choices.

nice.org.uk

guidance.nice.org.uk

National Institute for Health and Clinical Excellence. Clinical guideline 101: Chronic Obstructive Pulmonary Disease. London, June 2010.
National Institute for Health and Clinical Excellence. Clinical guideline 101: Chronic Obstructive Pulmonary Disease. London, June 2010.

nih.gov

ncbi.nlm.nih.gov

Rabe KF, Hurd S, Anzueto A, et al. (2007). "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary". Am. J. Respir. Crit. Care Med. 176 (6): 532–55. doi:10.1164/rccm.200703-456SO. பப்மெட்:17507545.
Hogg JC, Chu F, Utokaparch S, et al. (2004). "The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease". N. Engl. J. Med. 350 (26): 2645–53. doi:10.1056/NEJMoa032158. பப்மெட்:15215480.
Decramer M, Janssens W, Miravitlles M (April 2012). "நாட்பட்ட நுரையீரல் அடைப்பு வளர்ந்து வரும் நோய்". Lancet 379 (9823): 1341–51. doi:10.1016/S0140-6736(11)60968-9. பப்மெட்:22314182.
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J (September 2007). "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary". Am. J. Respir. Crit. Care Med. 176 (6): 532–55. doi:10.1164/rccm.200703-456SO. பப்மெட்:17507545. http://ajrccm.atsjournals.org/content/176/6/532.long.
Nathell L, Nathell M, Malmberg P, Larsson K (2007). "COPD diagnosis related to different guidelines and spirometry techniques". Respir. Res. 8 (1): 89. doi:10.1186/1465-9921-8-89. பப்மெட்:18053200.
Mathers CD, Loncar D (November 2006). "Projections of global mortality and burden of disease from 2002 to 2030". PLoS Med. 3 (11): e442. doi:10.1371/journal.pmed.0030442. பப்மெட்:17132052. பப்மெட் சென்ட்ரல்:1664601. http://dx.plos.org/10.1371/journal.pmed.0030442.
Mathers CD, Loncar D (November 2006). "Projections of Global Mortality and Burden of Disease from 2002 to 2030". PLoS Med. 3 (11): e442. doi:10.1371/journal.pmed.0030442. பப்மெட்:17132052. பப்மெட் சென்ட்ரல்:1664601. http://dx.plos.org/10.1371/journal.pmed.0030442.
Mahler DA (2006). "Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease". Proceedings of the American Thoracic Society 3 (3): 234–8. doi:10.1513/pats.200509-103SF. பப்மெட்:16636091.
Holland AE, Hill CJ, Jones AY, McDonald CF (2012). Holland, Anne E. ed. "Breathing exercises for chronic obstructive pulmonary disease". Cochrane Database Syst Rev 10: CD008250. doi:10.1002/14651858.CD008250.pub2. பப்மெட்:23076942.
Weitzenblum E, Chaouat A (2009). "Cor pulmonale". Chron Respir Dis 6 (3): 177–85. doi:10.1177/1479972309104664. பப்மெட்:19643833.
Brulotte CA, Lang ES (May 2012). "Acute exacerbations of chronic obstructive pulmonary disease in the emergency department". Emerg. Med. Clin. North Am. 30 (2): 223–47, vii. doi:10.1016/j.emc.2011.10.005. பப்மெட்:22487106.
Laniado-Laborín, R (January 2009). "Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21st century". International journal of environmental research and public health 6 (1): 209–24. doi:10.3390/ijerph6010209. பப்மெட்:19440278.
Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD (August 2009). "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history". Eur. Respir. J. 34 (2): 380–6. doi:10.1183/09031936.00144208. பப்மெட்:19196816.
Devereux, Graham (May 2006). "ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors". BMJ 332 (7550): 1142–4. doi:10.1136/bmj.332.7550.1142. பப்மெட்:16690673.
Hnizdo E, Vallyathan V (April 2003). "Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence". Occup Environ Med 60 (4): 237–43. doi:10.1136/oem.60.4.237. பப்மெட்:12660371.
Pirozzi C, Scholand MB (July 2012). "Smoking cessation and environmental hygiene". Med. Clin. North Am. 96 (4): 849–67. doi:10.1016/j.mcna.2012.04.014. பப்மெட்:22793948. https://archive.org/details/sim_medical-clinics-of-north-america_2012-07_96_4/page/849.
Devereux, Graham (2006). "Definition, epidemiology and risk factors". BMJ 332 (7550): 1142–4. doi:10.1136/bmj.332.7550.1142. பப்மெட்:16690673.
Rushton, Lesley (2007). "Chronic Obstructive Pulmonary Disease and Occupational Exposure to Silica". Reviews on Environmental Health 22 (4): 255–72. doi:10.1515/REVEH.2007.22.4.255. பப்மெட்:18351226.
Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM (September 2006). "Global burden of COPD: systematic review and meta-analysis". Eur. Respir. J. 28 (3): 523–32. doi:10.1183/09031936.06.00124605. பப்மெட்:16611654.
Kennedy SM, Chambers R, Du W, Dimich-Ward H (December 2007). "Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?". Proceedings of the American Thoracic Society 4 (8): 692–4. doi:10.1513/pats.200707-094SD. பப்மெட்:18073405. http://pats.atsjournals.org/cgi/content/full/4/8/692.
Kennedy SM, Chambers R, Du W, Dimich-Ward H (December 2007). "Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?". Proceedings of the American Thoracic Society 4 (8): 692–4. doi:10.1513/pats.200707-094SD. பப்மெட்:18073405. http://pats.atsjournals.org/cgi/content/full/4/8/692.
Silverman EK, Chapman HA, Drazen JM, et al. (June 1998). "Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis". Am. J. Respir. Crit. Care Med. 157 (6 Pt 1): 1770–8. பப்மெட்:9620904. http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=9620904.
Foreman MG, Campos M, Celedón JC (July 2012). "Genes and chronic obstructive pulmonary disease". Med. Clin. North Am. 96 (4): 699–711. doi:10.1016/j.mcna.2012.02.006. பப்மெட்:22793939.
Brode SK, Ling SC, Chapman KR (September 2012). "Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease". CMAJ 184 (12): 1365–71. doi:10.1503/cmaj.111749. பப்மெட்:22761482.
Beasley, V; Joshi, PV; Singanayagam, A; Molyneaux, PL; Johnston, SL; Mallia, P (2012). "Lung microbiology and exacerbations in COPD". International journal of chronic obstructive pulmonary disease 7: 555–69. doi:10.2147/COPD.S28286. பப்மெட்:22969296.
Calverley PM, Koulouris NG (2005). "Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology". Eur Respir J 25 (1): 186–199. doi:10.1183/09031936.04.00113204. பப்மெட்:15640341.
O'Donnell DE (2006). "Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease". The Proceedings of the American Thoracic Society 3 (2): 180–4. doi:10.1513/pats.200508-093DO. பப்மெட்:16565429.
Agustí A, MacNee W, Donaldson K, Cosio M. (2003). "Hypothesis: does COPD have an autoimmune component?". Thorax 58 (10): 832–4. doi:10.1136/thorax.58.10.832. பப்மெட்:14514931.
Rutgers, Steven R.; Postma, Dirkje S.; Ten Hacken, Nick H. .T.; Kauffman, Henk F.;van der Mark,Thomas W; Koeter, Gerard H.; Timens, Wim (2000). "Ongoing airway inflammation in patients with COPD who do not currently smoke". Thorax 55 (1): 12–18. doi:10.1136/thorax.55.1.12. பப்மெட்:10607796.
Feghali-Bostwick CA, Gadgil AS, Otterbein LE, et al. (January 2008). "Autoantibodies in patients with chronic obstructive pulmonary disease". Am. J. Respir. Crit. Care Med. 177 (2): 156–63. doi:10.1164/rccm.200701-014OC. பப்மெட்:17975205.
Lee SH, Goswami S, Grudo A, et al. (May 2007). "Antielastin autoimmunity in tobacco smoking-induced emphysema". Nat. Med. 13 (5): 567–9. doi:10.1038/nm1583. பப்மெட்:17450149.
Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P (August 2011). "Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society". Ann. Intern. Med. 155 (3): 179–91. doi:10.7326/0003-4819-155-3-201108020-00008. பப்மெட்:21810710.
Kitaguchi Y, Fujimoto K, Kubo K, Honda T (October 2006). "Characteristics of COPD phenotypes classified according to the findings of HRCT". Respir Med 100 (10): 1742–52. doi:10.1016/j.rmed.2006.02.003. பப்மெட்:16549342. http://linkinghub.elsevier.com/retrieve/pii/S0954-6111(06)00064-3.
Paoletti M, Camiciottoli G, Meoni E, et al. (December 2009). "Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes". J Biomed Inform 42 (6): 1013–21. doi:10.1016/j.jbi.2009.05.008. பப்மெட்:19501190. http://linkinghub.elsevier.com/retrieve/pii/S1532-0464(09)00080-X.
Petty TL (2002). "COPD: clinical phenotypes". Pulm Pharmacol Ther 15 (4): 341–51. doi:10.1006/pupt.2002.0380. பப்மெட்:12220938. http://linkinghub.elsevier.com/retrieve/pii/S1094-5539(02)90380-9.
Torres M, Moayedi S (May 2007). "Evaluation of the acutely dyspneic elderly patient". Clin. Geriatr. Med. 23 (2): 307–25, vi. doi:10.1016/j.cger.2007.01.007. பப்மெட்:17462519. https://archive.org/details/sim_clinics-in-geriatric-medicine_2007-05_23_2/page/307.
Badgett RG, Tanaka DJ, Hunt DK, et al. (1994). "The clinical evaluation for diagnosing obstructive airways disease in high-risk patients". Chest 106 (5): 1427–31. doi:10.1378/chest.106.1427. பப்மெட்:7956395. https://archive.org/details/sim_chest_1994-11_106_5/page/1427.
Holleman DR, Simel DL (1995). "Does the clinical examination predict airflow limitation?". JAMA 273 (4): 313–9. doi:10.1001/jama.273.4.313. பப்மெட்:7815660.
Celli BR, Cote CG, Marin JM, et al. (March 2004). "The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease". N. Engl. J. Med. 350 (10): 1005–12. doi:10.1056/NEJMoa021322. பப்மெட்:14999112. https://archive.org/details/sim_new-england-journal-of-medicine_2004-03-04_350_10/page/n87.
Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E (November 2008). "Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis". JAMA 300 (20): 2407–16. doi:10.1001/jama.2008.717. பப்மெட்:19033591.
Mackay AJ, Hurst JR (July 2012). "COPD exacerbations: causes, prevention, and treatment". Med. Clin. North Am. 96 (4): 789–809. doi:10.1016/j.mcna.2012.02.008. பப்மெட்:22793945. https://archive.org/details/sim_medical-clinics-of-north-america_2012-07_96_4/page/789.
Poole PJ, Chacko E, Wood-Baker RW, Cates CJ (2006). Poole, Phillippa. ed. "Influenza vaccine for patients with chronic obstructive pulmonary disease". Cochrane Database Syst Rev (1): CD002733. doi:10.1002/14651858.CD002733.pub2. பப்மெட்:16437444.
Jiménez-Ruiz CA, Fagerström KO (March 2013). "Smoking cessation treatment for COPD smokers: the role of counselling". Monaldi Arch Chest Dis 79 (1): 33–7. பப்மெட்:23741944.
Tønnesen P (March 2013). "Smoking cessation and COPD". Eur Respir Rev 22 (127): 37–43. doi:10.1183/09059180.00007212. பப்மெட்:23457163.
Carlucci A, Guerrieri A, Nava S (December 2012). "Palliative care in COPD patients: is it only an end-of-life issue?". Eur Respir Rev 21 (126): 347–54. doi:10.1183/09059180.00001512. பப்மெட்:23204123.
Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J (2011). Puhan, Milo A. ed. "Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease". Cochrane Database Syst Rev (10): CD005305. doi:10.1002/14651858.CD005305.pub3. பப்மெட்:21975749.
Lacasse Y, Goldstein R, Lasserson TJ, Martin S (2006). Lacasse, Yves. ed. "Pulmonary rehabilitation for chronic obstructive pulmonary disease". Cochrane Database Syst Rev (4): CD003793. doi:10.1002/14651858.CD003793.pub2. பப்மெட்:17054186.
Ferreira IM, Brooks D, White J, Goldstein R (2012). Ferreira, Ivone M. ed. "Nutritional supplementation for stable chronic obstructive pulmonary disease". Cochrane Database Syst Rev 12: CD000998. doi:10.1002/14651858.CD000998.pub3. பப்மெட்:23235577.
Liesker JJ, Wijkstra PJ, Ten Hacken NH, Koëter GH, Postma DS, Kerstjens HA (February 2002). "A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD". Chest 121 (2): 597–608. doi:10.1378/chest.121.2.597. பப்மெட்:11834677. http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=11834677. ^{[தொடர்பிழந்த இணைப்பு]}
van Dijk WD, van den Bemt L, van Weel C (2013). "Megatrials for bronchodilators in chronic obstructive pulmonary disease (COPD) treatment: time to reflect". J Am Board Fam Med 26 (2): 221–4. doi:10.3122/jabfm.2013.02.110342. பப்மெட்:23471939.
Liesker JJ, Wijkstra PJ, Ten Hacken NH, Koëter GH, Postma DS, Kerstjens HA (February 2002). "A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD". Chest 121 (2): 597–608. doi:10.1378/chest.121.2.597. பப்மெட்:11834677. http://journal.publications.chestnet.org/article.aspx?articleid=1080303.
Salpeter SR, Buckley NS, Salpeter EE (October 2006). "Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD". J Gen Intern Med 21 (10): 1011–9. doi:10.1111/j.1525-1497.2006.00507.x. பப்மெட்:16970553.
Chong J, Karner C, Poole P (2012). Chong, Jimmy. ed. "Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease". Cochrane Database Syst Rev 9: CD009157. doi:10.1002/14651858.CD009157.pub2. பப்மெட்:22972134.
Karner C, Cates CJ (2012). Karner, Charlotta. ed. "Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease". Cochrane Database Syst Rev 4: CD008989. doi:10.1002/14651858.CD008989.pub2. பப்மெட்:22513969.
Calverley PM, Anderson JA, Celli B, et al. (2007). "Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease". N. Engl. J. Med. 356 (8): 775–89. doi:10.1056/NEJMoa063070. பப்மெட்:17314337.
Cave, AC.; Hurst, MM. (May 2011). "The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis". Pharmacol Ther 130 (2): 114–43. doi:10.1016/j.pharmthera.2010.12.008. பப்மெட்:21276815.
Spencer, S; Karner, C; Cates, CJ; Evans, DJ (Dec 7, 2011). Spencer, Sally. ed. "Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease". The Cochrane database of systematic reviews (12): CD007033. doi:10.1002/14651858.CD007033.pub3. பப்மெட்:22161409.
Wang, J; Nie, B; Xiong, W; Xu, Y (April 2012). "Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis". Journal of clinical pharmacy and therapeutics 37 (2): 204–11. doi:10.1111/j.1365-2710.2011.01285.x. பப்மெட்:21740451.
Decramer ML, Hanania NA, Lötvall JO, Yawn BP (2013). "The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease". Int J Chron Obstruct Pulmon Dis 8: 53–64. doi:10.2147/COPD.S39018. பப்மெட்:23378756.
Nannini, LJ; Lasserson, TJ; Poole, P (Sep 12, 2012). Nannini, Luis Javier. ed. "Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease". The Cochrane database of systematic reviews 9: CD006829. doi:10.1002/14651858.CD006829.pub2. பப்மெட்:22972099.
Tashkin DP, Celli B, Senn S, et al. (October 2008). "A 4-year trial of tiotropium in chronic obstructive pulmonary disease". N. Engl. J. Med. 359 (15): 1543–54. doi:10.1056/NEJMoa0805800. பப்மெட்:18836213.
O'Donnell DE, Flüge T, Gerken F, et al. (June 2004). "Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD". Eur Respir J 23 (6): 832–40. doi:10.1183/09031936.04.00116004. பப்மெட்:15218994. http://erj.ersjournals.com/cgi/pmidlookup?view=long&pmid=15218994.
Cheyne L, Irvin-Sellers MJ, White J (Sep 16, 2013). Cheyne, Leanne. ed. "Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease". Cochrane Database of Systematic Reviews 9 (9): CD009552. doi:10.1002/14651858.CD009552.pub2. பப்மெட்:24043433.
Karner, C; Chong, J; Poole, P (Jul 11, 2012). Karner, Charlotta. ed. "Tiotropium versus placebo for chronic obstructive pulmonary disease". The Cochrane database of systematic reviews 7: CD009285. doi:10.1002/14651858.CD009285.pub2. பப்மெட்:22786525.
Singh S, Loke YK, Furberg CD (September 2008). "Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis". JAMA 300 (12): 1439–50. doi:10.1001/jama.300.12.1439. பப்மெட்:18812535.
Singh S, Loke YK, Enright P, Furberg CD (January 2013). "Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications". Thorax 68 (1): 114–6. doi:10.1136/thoraxjnl-2011-201275. பப்மெட்:22764216.
Jones, P (Apr 2013). "Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review.". Advances in therapy 30 (4): 354–68. doi:10.1007/s12325-013-0019-2. பப்மெட்:23553509.
Cazzola, M; Page, CP; Matera, MG (Jun 2013). "Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.". Expert opinion on pharmacotherapy 14 (9): 1205–14. doi:10.1517/14656566.2013.789021. பப்மெட்:23566013.
Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD (January 2010). "Cardiovascular events associated with ipratropium bromide in COPD". Chest 137 (1): 13–9. doi:10.1378/chest.08-2367. பப்மெட்:19363211. http://chestjournal.chestpubs.org/content/137/1/13.abstract.
Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP (January 2010). "Cardiovascular safety of tiotropium in patients with COPD". Chest 137 (1): 20–30. doi:10.1378/chest.09-0011. பப்மெட்:19592475. http://chestjournal.chestpubs.org/content/137/1/20.abstract.
Pinto-Plata VM, Müllerova H, Toso JF, et al. (January 2006). "C-reactive protein in patients with COPD, control smokers and non-smokers". Thorax 61 (1): 23–8. doi:10.1136/thx.2005.042200. பப்மெட்:16143583.
Gartlehner G, Hansen RA, Carson SS, Lohr KN (2006). "Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes". Ann Fam Med 4 (3): 253–62. doi:10.1370/afm.517. பப்மெட்:16735528.
Gartlehner G, Hansen RA, Carson SS, Lohr KN (2006). "Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes". Ann Fam Med 4 (3): 253–62. doi:10.1370/afm.517. பப்மெட்:16735528.
Shafazand S (June 2013). "ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPD". Ann. Intern. Med. 158 (12): JC2. doi:10.7326/0003-4819-158-12-201306180-02002. பப்மெட்:23778926.
Zhou Y, Wang X, Zeng X, et al. (2006). "Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year". Respirology 11 (5): 603–10. doi:10.1111/j.1440-1843.2006.00897.x. பப்மெட்:16916334.
Rennard SI, Fogarty C, Kelsen S, et al. (May 2007). "The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease". Am. J. Respir. Crit. Care Med. 175 (9): 926–34. doi:10.1164/rccm.200607-995OC. பப்மெட்:17290043.
Mammen MJ, Sethi S (2012). "Macrolide therapy for the prevention of acute exacerbations in chronic obstructive pulmonary disease". Pol. Arch. Med. Wewn. 122 (1–2): 54–9. பப்மெட்:22353707.
Herath, SC; Poole, P (Nov 28, 2013). "Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).". The Cochrane database of systematic reviews 11: CD009764. doi:10.1002/14651858.CD009764.pub2. பப்மெட்:24288145.
Simoens, S; Laekeman, G; Decramer, M (May 2013). "Preventing COPD exacerbations with macrolides: a review and budget impact analysis". Respiratory medicine 107 (5): 637–48. doi:10.1016/j.rmed.2012.12.019. பப்மெட்:23352223.
Barr RG, Rowe BH, Camargo CA (2003). Barr, R Graham. ed. "Methylxanthines for exacerbations of chronic obstructive pulmonary disease". Cochrane Database Syst Rev (2): CD002168. doi:10.1002/14651858.CD002168. பப்மெட்:12804425.
"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party". Lancet 1 (8222): 681–6. March 1981. பப்மெட்:6110912. http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(81)91970-X.
COPD Working, Group (2012). "Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis". Ontario health technology assessment series 12 (7): 1–64. பப்மெட்:23074435.
Bradley JM, O'Neill B (2005). Bradley, Judy M. ed. "Short-term ambulatory oxygen for chronic obstructive pulmonary disease". Cochrane Database Syst Rev (4): CD004356. doi:10.1002/14651858.CD004356.pub3. பப்மெட்:16235359.
Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A (2011). Abernethy, Amy. ed. "Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease". Cochrane Database Syst Rev (6): CD006429. doi:10.1002/14651858.CD006429.pub2. பப்மெட்:21678356.
O'Driscoll, BR; Howard, LS; Davison, AG; British Thoracic, Society (October 2008). "BTS guideline for emergency oxygen use in adult patients". Thorax 63 (Suppl 6): vi1–68. doi:10.1136/thx.2008.102947. பப்மெட்:18838559.
Lacasse Y, Brosseau L, Milne S, et al. (2002). "Pulmonary rehabilitation for chronic obstructive pulmonary disease". Cochrane database of systematic reviews (Online) (3): CD003793. doi:10.1002/14651858.CD003793. பப்மெட்:12137716.
Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA (2012). Vollenweider, Daniela J. ed. "Antibiotics for exacerbations of chronic obstructive pulmonary disease". Cochrane Database Syst Rev 12: CD010257. doi:10.1002/14651858.CD010257. பப்மெட்:23235687.
Jeppesen, E; Brurberg, KG; Vist, GE; Wedzicha, JA; Wright, JJ; Greenstone, M; Walters, JA (May 16, 2012). "Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.". The Cochrane database of systematic reviews 5: CD003573. doi:10.1002/14651858.CD003573.pub2. பப்மெட்:22592692.
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, et al. (December 2012). "Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet 380 (9859): 2197–223. doi:10.1016/S0140-6736(12)61689-4. பப்மெட்:23245608.
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al. (December 2012). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. பப்மெட்:23245607.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, et al. (December 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. பப்மெட்:23245604.
Rycroft CE, Heyes A, Lanza L, Becker K (2012). "Epidemiology of chronic obstructive pulmonary disease: a literature review". Int J Chron Obstruct Pulmon Dis 7: 457–94. doi:10.2147/COPD.S32330. பப்மெட்:22927753.
Simpson CR, Hippisley-Cox J, Sheikh A (2010). "Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients". Brit J Gen Pract 60 (576): 483–. doi:10.3399/bjgp10X514729. பப்மெட்:20594429.
Centers for Disease Control and Prevention (Nov 23, 2012). "Chronic Obstructive Pulmonary Disease Among Adults — United States, 2011". Morbidity and Mortality Weekly Report 61 (46): 938–43. பப்மெட்:23169314. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a2.htm.
Torio CM, Andrews RM (2006). "National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160". Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (Agency for Health Care Policy and Research). பப்மெட்:24199255. http://hcup-us.ahrq.gov/reports/statbriefs/sb160.jsp. பார்த்த நாள்: 2014-10-19.
Ziment, Irwin (1991). "History of the Treatment of Chronic Bronchitis". Respiration 58 (Suppl 1): 37–42. doi:10.1159/000195969. பப்மெட்:1925077.
Petty TL (2006). "The history of COPD". Int J Chron Obstruct Pulmon Dis 1 (1): 3–14. doi:10.2147/copd.2006.1.1.3. பப்மெட்:18046898.
Fishman AP (May 2005). "One hundred years of chronic obstructive pulmonary disease". Am. J. Respir. Crit. Care Med. 171 (9): 941–8. doi:10.1164/rccm.200412-1685OE. பப்மெட்:15849329.
Petty TL (2006). "The history of COPD". Int J Chron Obstruct Pulmon Dis 1 (1): 3–14. பப்மெட்:18046898.
Fishman AP (May 2005). "One hundred years of chronic obstructive pulmonary disease". Am. J. Respir. Crit. Care Med. 171 (9): 941–8. doi:10.1164/rccm.200412-1685OE. பப்மெட்:15849329.
Inamdar, AC; Inamdar, AA (Oct 2013). "Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.". Experimental lung research 39 (8): 315–27. doi:10.3109/01902148.2013.816803. பப்மெட்:23992090.
Conese, M; Piro, D; Carbone, A; Castellani, S; Di Gioia, S (2014). "Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity.". TheScientificWorldJournal 2014: 859817. doi:10.1155/2014/859817. பப்மெட்:24563632.
Wright, JL; Churg, A (December 2002). "Animal models of cigarette smoke-induced COPD". Chest 122 (6 Suppl): 301S–6S. doi:10.1378/chest.122.6_suppl.301S. பப்மெட்:12475805.
Churg, A; Wright, JL (2007). "Animal models of cigarette smoke-induced chronic obstructive lung disease". Contributions to microbiology. Contributions to Microbiology 14: 113–25. doi:10.1159/000107058. பன்னாட்டுத் தரப்புத்தக எண்:3-8055-8332-X. பப்மெட்:17684336.
Marinkovic D, Aleksic-Kovacevic S, Plamenac P (2007). "Cellular basis of chronic obstructive pulmonary disease in horses". Int. Rev. Cytol.. International Review of Cytology 257: 213–47. doi:10.1016/S0074-7696(07)57006-3. பன்னாட்டுத் தரப்புத்தக எண்:978-0-12-373701-4. பப்மெட்:17280899.
Miller MS, Tilley LP, Smith FW (January 1989). "Cardiopulmonary disease in the geriatric dog and cat". Vet. Clin. North Am. Small Anim. Pract. 19 (1): 87–102. பப்மெட்:2646821.

pubmedcentral.nih.gov

Nathell L, Nathell M, Malmberg P, Larsson K (2007). "COPD diagnosis related to different guidelines and spirometry techniques". Respir. Res. 8 (1): 89. doi:10.1186/1465-9921-8-89. பப்மெட்:18053200.
Laniado-Laborín, R (January 2009). "Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21st century". International journal of environmental research and public health 6 (1): 209–24. doi:10.3390/ijerph6010209. பப்மெட்:19440278.
Devereux, Graham (May 2006). "ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors". BMJ 332 (7550): 1142–4. doi:10.1136/bmj.332.7550.1142. பப்மெட்:16690673.
Hnizdo E, Vallyathan V (April 2003). "Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence". Occup Environ Med 60 (4): 237–43. doi:10.1136/oem.60.4.237. பப்மெட்:12660371.
Devereux, Graham (2006). "Definition, epidemiology and risk factors". BMJ 332 (7550): 1142–4. doi:10.1136/bmj.332.7550.1142. பப்மெட்:16690673.
Foreman MG, Campos M, Celedón JC (July 2012). "Genes and chronic obstructive pulmonary disease". Med. Clin. North Am. 96 (4): 699–711. doi:10.1016/j.mcna.2012.02.006. பப்மெட்:22793939.
Brode SK, Ling SC, Chapman KR (September 2012). "Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease". CMAJ 184 (12): 1365–71. doi:10.1503/cmaj.111749. பப்மெட்:22761482.
Beasley, V; Joshi, PV; Singanayagam, A; Molyneaux, PL; Johnston, SL; Mallia, P (2012). "Lung microbiology and exacerbations in COPD". International journal of chronic obstructive pulmonary disease 7: 555–69. doi:10.2147/COPD.S28286. பப்மெட்:22969296.
Agustí A, MacNee W, Donaldson K, Cosio M. (2003). "Hypothesis: does COPD have an autoimmune component?". Thorax 58 (10): 832–4. doi:10.1136/thorax.58.10.832. பப்மெட்:14514931.
Rutgers, Steven R.; Postma, Dirkje S.; Ten Hacken, Nick H. .T.; Kauffman, Henk F.;van der Mark,Thomas W; Koeter, Gerard H.; Timens, Wim (2000). "Ongoing airway inflammation in patients with COPD who do not currently smoke". Thorax 55 (1): 12–18. doi:10.1136/thorax.55.1.12. பப்மெட்:10607796.
Feghali-Bostwick CA, Gadgil AS, Otterbein LE, et al. (January 2008). "Autoantibodies in patients with chronic obstructive pulmonary disease". Am. J. Respir. Crit. Care Med. 177 (2): 156–63. doi:10.1164/rccm.200701-014OC. பப்மெட்:17975205.
Salpeter SR, Buckley NS, Salpeter EE (October 2006). "Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD". J Gen Intern Med 21 (10): 1011–9. doi:10.1111/j.1525-1497.2006.00507.x. பப்மெட்:16970553.
Decramer ML, Hanania NA, Lötvall JO, Yawn BP (2013). "The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease". Int J Chron Obstruct Pulmon Dis 8: 53–64. doi:10.2147/COPD.S39018. பப்மெட்:23378756.
Pinto-Plata VM, Müllerova H, Toso JF, et al. (January 2006). "C-reactive protein in patients with COPD, control smokers and non-smokers". Thorax 61 (1): 23–8. doi:10.1136/thx.2005.042200. பப்மெட்:16143583.
Gartlehner G, Hansen RA, Carson SS, Lohr KN (2006). "Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes". Ann Fam Med 4 (3): 253–62. doi:10.1370/afm.517. பப்மெட்:16735528.
Gartlehner G, Hansen RA, Carson SS, Lohr KN (2006). "Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes". Ann Fam Med 4 (3): 253–62. doi:10.1370/afm.517. பப்மெட்:16735528.
COPD Working, Group (2012). "Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis". Ontario health technology assessment series 12 (7): 1–64. பப்மெட்:23074435.
Rycroft CE, Heyes A, Lanza L, Becker K (2012). "Epidemiology of chronic obstructive pulmonary disease: a literature review". Int J Chron Obstruct Pulmon Dis 7: 457–94. doi:10.2147/COPD.S32330. பப்மெட்:22927753.
Simpson CR, Hippisley-Cox J, Sheikh A (2010). "Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients". Brit J Gen Pract 60 (576): 483–. doi:10.3399/bjgp10X514729. பப்மெட்:20594429.
Petty TL (2006). "The history of COPD". Int J Chron Obstruct Pulmon Dis 1 (1): 3–14. doi:10.2147/copd.2006.1.1.3. பப்மெட்:18046898.
Petty TL (2006). "The history of COPD". Int J Chron Obstruct Pulmon Dis 1 (1): 3–14. பப்மெட்:18046898.
Conese, M; Piro, D; Carbone, A; Castellani, S; Di Gioia, S (2014). "Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity.". TheScientificWorldJournal 2014: 859817. doi:10.1155/2014/859817. பப்மெட்:24563632.

nhlbi.nih.gov

U.S. National Heart Lung and Blood Institute - What is COPD
U.S. National Heart Lung and Blood Institute - Signs and Symptoms
"What Are the Signs and Symptoms of COPD?". National Heart, Lung, and Blood Institute. July 31, 2013. Retrieved November 29, 2013.
"COPD — Treatment". U.S. National Heart Lung and Blood Institute. Retrieved 2013-07-23.
U.S. National Heart Lung and Blood Institute - Treatment
MORBIDITY & MORTALITY: 2009 CHART BOOK ON CARDIOVASCULAR, LUNG, AND BLOOD DISEASES National Heart, Lung, and Blood Institute
"Morbidity & Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases" (PDF). National Heart, Lung, and Blood Institute.

nlm.nih.gov

MedlinePlus Encyclopedia Chronic obstructive pulmonary disease
MedlinePlus Encyclopedia Chronic obstructive pulmonary disease
MedlinePlus Encyclopedia 000091

plos.org

dx.plos.org

Mathers CD, Loncar D (November 2006). "Projections of global mortality and burden of disease from 2002 to 2030". PLoS Med. 3 (11): e442. doi:10.1371/journal.pmed.0030442. பப்மெட்:17132052. பப்மெட் சென்ட்ரல்:1664601. http://dx.plos.org/10.1371/journal.pmed.0030442.
Mathers CD, Loncar D (November 2006). "Projections of Global Mortality and Burden of Disease from 2002 to 2030". PLoS Med. 3 (11): e442. doi:10.1371/journal.pmed.0030442. பப்மெட்:17132052. பப்மெட் சென்ட்ரல்:1664601. http://dx.plos.org/10.1371/journal.pmed.0030442.

pubmedcentral.gov

Mathers CD, Loncar D (November 2006). "Projections of global mortality and burden of disease from 2002 to 2030". PLoS Med. 3 (11): e442. doi:10.1371/journal.pmed.0030442. பப்மெட்:17132052. பப்மெட் சென்ட்ரல்:1664601. http://dx.plos.org/10.1371/journal.pmed.0030442.
Mathers CD, Loncar D (November 2006). "Projections of Global Mortality and Burden of Disease from 2002 to 2030". PLoS Med. 3 (11): e442. doi:10.1371/journal.pmed.0030442. பப்மெட்:17132052. பப்மெட் சென்ட்ரல்:1664601. http://dx.plos.org/10.1371/journal.pmed.0030442.

reference.com

dictionary.reference.com

"Emphysema". Dictionary.com. Retrieved 21 November 2013.

thefreedictionary.com

medical-dictionary.thefreedictionary.com

"Pink Puffer - definition of Pink Puffer in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia". Medical-dictionary.thefreedictionary.com. Retrieved 2013-07-23.

thoracic.org

"COPD Assessment Test (CAT)". American Thoracic Society. Retrieved November 29, 2013.

toolserver.org

எஆசு:10.1016/S0140-6736(06)68516-4
This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand

web.archive.org

"MedicineNet.com - COPD signs & symptoms". Archived from the original on 2010-06-04. Retrieved 2010-06-03.
"MedicineNet.com - COPD causes". Archived from the original on 2010-06-03. Retrieved 2010-06-03.
"Definition of pack year - NCI Dictionary of Cancer Terms". Archived from the original on 2009-05-10.
BTS COPD Consortium (2005). "Spirometry in practice - a practical guide to using spirometry in primary care". pp. 8–9. Archived from the original on 26 ஆகஸ்ட் 2014. Retrieved 25 August 2014. {{cite web}}: Check date values in: |archive-date= (help)
Vestbo, Jørgen (2013). "Introduction". Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (PDF). Global Initiative for Chronic Obstructive Lung Disease. pp. xiii–xv. Archived from the original (PDF) on 2013-10-04. Retrieved 2014-10-19. {{cite book}}: Unknown parameter |nopp= ignored (help)
Vestbo, Jørgen (2013). "Management of Stable COPD". Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (PDF). Global Initiative for Chronic Obstructive Lung Disease. pp. 31–8. Archived from the original (PDF) on 2013-10-04. Retrieved 2014-10-19.

weforum.org

www3.weforum.org

Bloom, D (2011). The Global Economic Burden of Noncommunicable Diseases (PDF). World Economic Forum. p. 24.

who.int

"The 10 leading causes of death in the world, 2000 and 2011". World Health Organization. July 2013. Retrieved November 29, 2013.
World Health Organization (2008). WHO Report on the Global Tobacco Epidemic 2008: The MPOWER Package (PDF). Geneva: World Health Organization. pp. 268–309. ISBN 92-4-159628-7.
Policy Recommendations for Smoking Cessation and Treatment of Tobacco Dependence. World Health Organization. pp. 15–40. ISBN 978-92-4-156240-9.
"World Health Organization Tobacco Free Initiative - Policy recommendations for smoking cessation and treatment of tobacco dependence". Retrieved 28 July 2008. {{cite web}}: Unknown parameter |dateformat= ignored (help)
"WHO Disease and injury country estimates". World Health Organization. 2009. Retrieved Nov 11, 2009.
"Chronic obstructive pulmonary disease (COPD) Fact sheet N°315". WHO. November 2012.

wikipedia.org

ta.wikipedia.org

எஆசு:10.1016/S0140-6736(06)68516-4
This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand

en.wikipedia.org

Liesker JJ, Wijkstra PJ, Ten Hacken NH, Koëter GH, Postma DS, Kerstjens HA (February 2002). "A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD". Chest 121 (2): 597–608. doi:10.1378/chest.121.2.597. பப்மெட்:11834677. http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=11834677. ^{[தொடர்பிழந்த இணைப்பு]}

wrongdiagnosis.com

wrongdiagnosis.com > Prevalence and Incidence of COPD மார்ச் 14, 2010 -இல் எடுக்கப்பட்டது